Acrux (ARUXF) Pretax Margin %: 22.40% (As of Dec. 2025)


What is Acrux Pretax Margin %?

Acrux ARUXF Pretax Margin % is 22.40% as of Dec. 2025. The stock has 6 warning signs investors should review. Among 946 Biotechnology companies, Acrux ranks better than 52.43% on this metric.

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Acrux's Pre-Tax Income for the six months ended in Dec. 2025 was $0.26 Mil. Acrux's Revenue for the six months ended in Dec. 2025 was $1.16 Mil. Therefore, Acrux's pretax margin for the quarter that ended in Dec. 2025 was 22.40%.

The historical rank and industry rank for Acrux's Pretax Margin % or its related term are showing as below:

ARUXF' s Pretax Margin % Range Over the Past 10 Years
Min: -1320.92   Med: -528.17   Max: 64.59
Current: -69.93

ARUXF's Pretax Margin % is ranked better than
52.43% of 946 companies
in the Biotechnology industry
Industry Median: -90.5 vs ARUXF: -69.93

Acrux  (OTCPK:ARUXF) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.

Acrux Pretax Margin % Related Terms

Acrux Pretax Margin % Historical Data

* Premium members only.

The historical data trend for Acrux's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Acrux Pretax Margin % Chart

Acrux Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Pretax Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -930.04 -557.45 -2.51 -109.38 -498.71

Acrux Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Pretax Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -64.89 -396.69 -2,985.53 -219.94 22.40

ARUXF vs VRTX, REGN, ALNY: Pretax Margin % Comparison

For the Biotechnology subindustry, Acrux's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Acrux Pretax Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Acrux's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where Acrux's Pretax Margin % falls into.


Acrux Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

Acrux's Pretax Margin for the fiscal year that ended in Jun. 2025 is calculated as

Pretax Margin=Pre-Tax Income (A: Jun. 2025 )/Revenue (A: Jun. 2025 )
=-3.865/0.775
=-498.71 %

Acrux's Pretax Margin for the quarter that ended in Dec. 2025 is calculated as

Pretax Margin=Pre-Tax Income (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=0.259/1.156
=22.40 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Pretax Margin % →
What does a Pretax Margin % of 22.40% mean?
Acrux (ARUXF) has a Pretax Margin % of 22.40% as of Dec. 2025. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Acrux and its competitors. According to the industry distribution chart, Acrux ranks #450 out of 946 companies in the Biotechnology industry, placing it in the top 47.6%.
Is Acrux's Pretax Margin % too high?
Acrux's current Pretax Margin % is 22.40%. Based on the distribution chart, Acrux ranks #450 out of 946 companies in the Biotechnology industry, which is above the industry midpoint.
How does Acrux's Pretax Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Acrux ranks #450 out of 946 companies for Pretax Margin %. This puts Acrux in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Biotechnology company?
A good Pretax Margin % depends on the Biotechnology industry context. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Acrux and its competitors. Acrux's current Pretax Margin % is 22.40%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Acrux stock overvalued right now?
Based on GuruFocus' analysis, Acrux (ARUXF) is currently considered Possible Value Trap. The stock's GF Value™ is $0.03, compared to a current price of $0.02 — trading 43.7% below its estimated fair value. The current Pretax Margin % is 22.40%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For Acrux (ARUXF), the current Pretax Margin % is 22.40% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Acrux Business Description

Other Exchanges FJY:GermanyACR:Australia
Address 103-113 Stanley Street, West Melbourne, Melbourne, VIC, AUS, 3003
Acrux Ltd is a dynamic Australian drug delivery specialist with expertise in developing and commercialising patient-preferred healthcare products for world-wide markets. Its talent creates value through the development and commercialisation of healthcare products using owned or acquired technologies. The group's products are patient preferred, protected by patent or other means, and use creative drug delivery.